Biostream Therapeutics San Francisco, CA - 94109

Biostream Therapeutics is categorized under Medical Apparatus and Supplies in San Francisco, CA and active since 2003.

Biostream Therapeutics was established in 2003, and today employs 1 to 4, earning Unknown per year. This is a Medical Apparatus and Supplies business, which does work in the B2C market, and is classified as a Medical Apparatus and Supplies, under code number 9999900 by the NAICS.

If you are seeking more information, feel free to contact Bryan Gescuk, President at the company’s single location by writing to 2000 Van Ness Avenue # 506, San Francisco, California CA 94109 or by phoning (650) 573-2092. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Biostream Therapeutics
Contact Person: Bryan Gescuk, President
Address: 2000 Van Ness Avenue # 506, San Francisco, California 94109
Phone Number: (650) 573-2092
Annual Revenue (USD): Unknown
Founded: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Apparatus and Supplies
SIC Code: 5999
NAICS Code: 9999900
Share This Business:

Biostream Therapeutics was started in 2003 to provide professional Medical Apparatus and Supplies under the SIC code 5999 and NAICS code 9999900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Bryan Gescuk, President for inquiries that concern Biostream Therapeutics by calling the company number (650) 573-2092, as your correspondence is most welcome. Additionally, the physical location of the single location of Biostream Therapeutics can be found at the coordinates 37.79393,-122.42297 as well as the street address 2000 Van Ness Avenue # 506 in San Francisco, California 94109.

For its online presence, you may visit Biostream Therapeutics’s website at and engage with its social media outlets through on Twitter and on Facebook.